Investigation of the functions of candidate miRNAs in camptothecin-induced apoptosis in human cells by Demir, Şeyda


 
 
 
INVESTIGATION OF THE FUNCTIONS OF 
CANDIDATE miRNAs IN 
CAMPTOTHECIN-INDUCED APOPTOSIS IN 
HUMAN CELLS 

 
 
 
 
A Thesis Submitted to 
the Graduate School of Engineering and Sciences of 
zmir Institute of Technology 
in Partial Fulfillment of the Requirements for the Degree of 
 
MASTER OF SCIENCE 
 
in Molecular Biology and Genetics 
 
 
 
 
 
by 
 
eyda DEMR   
 
 
 
 
 
 
 
August 2012 
ZMR 
  
____________________________
Assoc. Prof. Dr. Ahmet KOÇ 
Head of Department of Molecular 
Biology and Genetics 
 
______________________________
Prof. Dr. R. Tuğrul SENGER 
Dean of the Graduate School of 
Engineering and Sciences 
We approve the thesis of  Şeyda DEMİR 
 
Examining Committee Members: 
 
 
 
 
______________________________ 
Assist. Prof. Dr. Bünyamin AKGÜL 
Department of Molecular Biology and Genetics, 
İzmir Institute of Technology 
 
 
 
 
______________________________ 
Assist. Prof. Dr. Ali ÇAĞIR 
Department of Molecular Biology and Genetics, 
İzmir Institute of Technology 
 
 
 
 
______________________________ 
Assist. Prof. Dr. Gülistan MEŞE ÖZÇİVİCİ 
Department of Chemistry, 
İzmir Institute of Technology 
 
 
 
                                                                                                               10 August 2012 
 
 
 
 
 
 
 
 
 
 
 
 
_______________________________ 
Assist. Prof. Dr. Bünyamin AKGÜL 
Supervisor, Department of Molecular 
Biology of Genetics 
İzmir Institute of Technology 


ACKNOWLEDGMENTS 
 
I would like to thank and express my gratitute to my advisor, Assist. Prof. Dr. 
Bünyamin AKGÜL for his guidance, understanding, motivation and  support during this 
study.  
Also I would like to express my grateful thanks to my committee members, 
Assist. Prof. Dr. Ayten Nalbant and Assist. Prof. Dr. Ali Çaır, Assist. Prof. Dr. 
Gülistan Mee Özçivici for their suggestion and contributions. 
I would like to thank my friends Leyla Öztürk, Gülden Yorgancıolu for their 
help, friendship and support all the time. 
Finally, I gratefully thank my family for  their excellent support, understanding, 
patience and encouragement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


ABSTRACT 
 
INVESTIGATION OF THE FUNCTIONS OF CANDIDATE miRNAs IN 
CAMPTOTHECIN INDUCED APOPTOSIS IN HUMAN CELLS  
 
MicroRNAs are non-coding 19-25nt long, small RNAs that regulate expression 
of about 30% of human genes by inhibiting mRNA translation or inducing its 
degradation. MicroRNAs play important role in cell growth, differentiation, apoptosis. 
miRNAs regulate apoptosis by targeting genes involved in apoptotic pathway as a pro 
or anti-apoptotic genes. This study has aimed to identify whether candidate miRNAs      
( miR-17* and miR-425) have a regulatory role in camptothecin induced apoptosis or 
not in Human cells and Hela cells that derived from cervical cancer were used as a 
model cell line. These candidates were selected based on deep sequencing data that 
showed some miRNAs differentially expressed after camptothecin treatment as 
compared with non-treated control group. 
To show candidate miRNAs whether have a role or not in regulation of  
camptothecin induced apoptosis, first Hela cells were transfected with candidate 
miRNAs then candidate miRNA over-expressed cells were treated with camptothecin 
eventually level of apoptosis was measured by flow cytometry and the results were 
evaluated by comparing miRNA over-expressed cell group with un-transfected control 
group. Active caspase-3 level also was measured by using flow cytometry and the data 
showed miR-17* and miR-425 function as pro-apoptotic regulator in camptothecin 
induced apoptosis in Hela cells. 
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ÖZET 
 
ADAY microRNA’ LARIN NSAN HÜCRELERNDE KAMPTOTESN 
LE NDÜKLENEN APOPTOZDAK FONKSYONLARININ 
ARATIRILMASI  
 
miRNA’lar kodlanmayan 19-25 nükleotid uzunluundaki küçük RNA lardır ve 
insan genomunun %30 unu mRNAların translasyonunu durdurarak yada yıkımına yol 
açarak düzenlerler. miRNAlar hücre geliimi, farklılaması ve apoptoz gibi önemli 
biyolojik olaylarda önemli bir yere sahiptir. Apoptotik mekanizmada yer alan anti yada 
pro-apoptotik gen hedeflerini baskılayarak apoptozu düzenlerler. 
Bu çalımada amaç aday miRNAların (miR-17* and miR-425) kamptotesin ile 
apoptozu aktive edilen insan hücrelerinde apoptozu düzenleyip düzenlemediinin 
belirlenmesidir. Bu çalımada Hela rahim azı kanseri hücre hattı model olarak 
kullanılmıtır.  Bu miRNA adayları kamptotesin ile indüklenen hücrelerin ve 
indüklenmeyen kontrol grubu hücrelerinin derin sekans sonuçlarının karılatırması 
sonucu kontrol grubuna göre ifade edilme seviyesinde farklılık olan miRNA ların 
seçilmesiyle belirlenmitir. 
Bu miRNA adaylarının kamptotesin ile apoptozu indüklenen insan hücrelerinde 
apoptozu düzenleyip düzenlemediini belirlemek için önce hücreler aday miRNA lar ile 
transfekte edilmi ve 24 saat sonra transfeksiyon ile bu miRNA ların aırı ifadadesinin 
salandıı hücreler kamptotesin ile 48 saat inkübe edilmitir. 48 saat sonra apoptoz 
oranları Flow Sitometre ile ölçülmü ve transfekte edilen hücre gruplarının apoptoz 
oranı transfekte edilmeyen kontrol grubuyla karılatırılarak sonuçlar 
deerlendirilmitir. Ayrıca aktif kaspaz-3 miktarı flow sitometre ile ölçülmütür. 
Sonuçlar miR-17* and miR-425’in apoptozu kamptotesin ile indüklenen Hela 
hücrelerinde pro-apoptotik bir fonksiyona sahip olduunu göstermitir. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1.  Apoptosis  
 
1.1.2. Definition of Apoptosis 
 
Apoptosis is programmed  of cell death and it was first  described in 1972 by 
Currie and colleagues (Kery and Wyllie 1972). Apoptosis is carried out by caspases that 
are a family of cysteine proteases and expressed as a inactive precursors. When death-
inducing stimuli comes, precursor caspases are activated by cleavage at specific aspartic 
residues. The caspases are divided into initiator and executionar caspases. Initiator 
caspases activate executionar caspases by cleavage them and executionar caspases 
execute apoptosis. (Yaron  and Hermann  2011)  Programmed cell death  plays an 
important role in development and tissue homeostatis. During development many cells 
are produced in excess then lots of them are eliminated by apoptosis to contribute to 
forming organs and tissues  (Jin and El-Deiry 2005). Defect in cell death pathway result 
in pathological conditions such as developmental defects,  autoimmune diseases, 
neurodegeneration or cancer  ( Jin and El-Deiry 2005, Blank and Shiloh 2007). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Changes in cell during apoptosis 
(Source: Raff 1998). 


 
During apoptosis cells undergo morphological changes such as exposure of 
phosphotidylserine on membrane surface, membrane blebbing, cytoplasmic shrinkage 
and reduction of cellular  volume , condensation of the chromatin, and fragmentation of  
the nucleus , all of them eventually  lead to formation of  apoptotic bodies that are 
engulfed by neighbouring cells and macrophages (Blank and Shiloh 2007, Jin and El-
Deiry 2005).  
 
1.1.3 Pathways of Apoptosis 
 
Apoptosis is induced by two signaling pathways; extrinsic pathway is initiated 
by death receptors and intrinsic pathway is induced by signals from  within the cell. 
Extrinsic pathway of apoptosis is induced when a death ligand binds to death  receptor 
at cell surface and this binding activates caspases that leads to apoptotic cell death. 
These death receptors are members of tumour necrosis factor (TNF) receptor 
superfamily, including Fas, TRAMP, TNF receptor 1 and 2, TRAIL receptor 1 and 2      
( Xu and Shi 2007, Blank and Shiloh 2007).  
Intrinsic pathway of apoptosis is initiated by intrinsic signals including DNA 
damage induced by irradiation or chemicals, growth factor deprivation or oxidative 
stress. These apoptotic signals  triggers  pro-apoptotic Bcl-2 proteins translocation to 
outer membrane of mitochondria which leads to  mitochondrial outer membrane 
permeabilization  (MOMP)  that leads to release of cytochrome c into cytosol from 
intermembrane space of  mitochondria and binding of cytochrome c to apoptotic 
protease-activating factor 1 (Apaf-1 ) leads to formation of a caspase activating 
complex called apoptosome that evokes activation of initiator and executioner caspases, 
usually caspase 9 and 3 respectively and apoptotic death occurs (Xu and Shi 2007, 
Blank and Shiloh 2007, Jin and El-Deiry 2005). 
 Besides the release cytochrome-c, the intramembrane content released also 
contains apoptosis inducing factor (AIF) to facilitate DNA fragmentation, and 
Smac/Diablo proteins to inhibit the inhibitor of apoptosis (IAP). (Hague and Paraskeva 
2004)   
 There are a variety of regulatory molecules that regulate apoptosis such as Bcl-2 
(B cell lymphoma 2) proteins, IAPs (Inhibitor of apoptosis), c-FLIP proteins 


Bcl-2 family members that regulate intrinsic pathway of apoptosis  consist of 
pro-apoptotic(Bax, Bak, Bad, Bim, Bid, Puma, Noxa)  and anti-apoptotic(Bcl2, Bcl-XL) 
members. Pro-apoptotic proteins induce  apoptosis by increasing release of cytochrome 
c whereas anti-apoptotic proteins inhibit apoptosis by suppress release of cytochrome c. 
IAPs regulate apoptosis by inhibiting activation of caspases. c-FLIP proteins inhibit 
death receptor induced apoptosis by inhibiting procaspase 8 activation (Chowdhury, et 
al. 2008) and also miRNAs have an important role in regulation of apoptosis. 
 
 
 
 
 
Figure 1.2. Pathways of apoptosis  
( Source: Xu and Shi 2007). 
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1.2. Camptothecin (CPT) 
 
As mentioned that before, intrinsic pathway of apoptosis is induced when DNA 
damage occurs and this damage can be carried out  by several reagents such as 
camptothecin (CPT), an antitumor extract of plant Camptotheca acuminata, which is a 
human topoisomerase I (TOP I) inhibitor (Li and Liu 2001, Pommier, et al. 2003). TOP 
I relaxes DNA supercoils by making single strand breaks (nicks) that facilitate 
separation of DNA strands to serve as a templates during replication, transcription, 
recombination, repair. In normal conditions, when the DNA is relaxed, TOP I religates 
the breaks but in the presense of camptothecin  religation step is inhibited because CPT  
binds to the TOP I-nicked DNA complex and this  prevents the re-ligation of the nicked 
strand (Pommier, et al. 2006). So, DNA damage occurs and this activates p53 that is 
tumor suppressor then p53 increases level of pro- apoptotic Bcl-2 proteins that enhance 
mitochondrial outer membrane permeabilization result in releasing of cytochrome c 
from mitochondria followed by caspase activation and apoptosis ( Shen, et al. 2001). 
 
 
 
Figure 1.3.  Camptothecin mechanism of action. TOP I relaxes DNA supercoil during replication, 
transcription by introducing single-strand breaks and after relaxation the breaks are 
relegated but in the presence of CPT, this religation is inhibited (Source: Pommier 2006). 
	
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1.3. MicroRNAs 
 
MicroRNAs (miRNAs) are endogenous non-coding small RNAs and regulate 
gene expression negatively by targeting 3’UTR of its target gene mRNA. (Julia Starega-
Roslan et al. 2011). miRNAs are 20 to 24 nucleotide long and control numerous 
physiological processes including cell proliferation, differentiation, development and  
play a significant role in regulating programmed cell death (Subramanian and Steeer 
2010). 
 
1.3.1 Biogenesis of miRNAs  
 
miRNAs are transcribed from intergenic or intronic region by RNA polimerase 
II as a  primary miRNAs (pri-miRNAs) that is a long transcript with one or more 
hairpin structures. In nucleus pri- miRNA is cleaved by Drosha /DGCR8 complex to 
form precursor miRNA (pre-miRNA) that  is about 60-70 nt hairpin structure and pre-
miRNA is transported to cytoplasm by Exportin-5 in Ran-GTP dependent pathway and 
in cytoplasm  pre-miRNA is further cleaved by Dicer/TRBP complex  thus mature 
miRNA dublex is generated then, one of strands that is named as a guide is selected to 
incorporate into RISC ( RNA Induced  Silencing Complex) and RISC is directed to 
target mRNAs that are complementary to its miRNA and this causes translational 
repression or degradation of target mRNA  and the other strand that is named as a 
passenger is degraded but this does not happen always like this sometimes passenger 
strand incorporates a RISC complex and this is called as ‘the star miRNA’ (Michael 
Ladomery, et al. 2011, Julia Starega-Roslan, et al. 2011). 


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Figure 1.4. Biogenesis of miRNA  
(Source:  Starega-Roslan, et al. 2011) 
 
1.4. miRNA-Mediated Regulation of Apoptosis 
 
More than 1000 miRNA have been identified in humans and these miRNA have 
regulatory role on hundreds of mRNAs (Starega-Roslan,  et al. 2011 and Friedman, et 
al. 2009 ). Many studies showed relationship between miRNAs and apoptosis. miRNAs 
can function as anti-apoptotic (oncomir) or pro-apoptotic (tumor suppressor) in 
programmed cell death (Kumar, et al. 2007). 
 miR-34a induces apoptosis in malignant peripheral nerve sheath tumor cell line 
(Subramanian, et al. 2010). miR-15 and miR-16 regulate anti-apoptotic members of 
Bcl-2 protein family, so they induce apoptosis in chronic lymphocytic leukemia (CLL) 
and other tumor cell lines (Cimmino,  et al.  2005). Let-7 behaves as a tumor suppressor 


by targeting HMGA2 and RAS oncogene expression and also regulates apoptosis by 
targeting caspase-3 ( Mayr, et al. 2007, Tsang and Kwok 2008). Mir-106b-25 cluster is 
up-regulated in gastric cancer cases. They suppress pro-apoptotic p21 and BCL2L11 
genes (Petrocca, et al. 2008). Recent studies showed that miR-21 is upregulated in 
various cancer types by targeting tumor suppressor genes, so these studies suggested 
that knocking down of miR-21 expression can be therapy for cancer treatment 
(Papagiannakopoulos, et al. 2008). miR-221 and miR-222 promote apoptosis by 
targeting p27 that is tumor suppressor gene and most targets of these miRNA are known 
as a pro- apoptotic, so up-regulation of miR-211 and miR-222 lead to cell proliferation 
and survival (Fornari, et al. 2008, Felli, et al. 2005). Activation of p53 is carried out by 
miR-29 family by suppressing expression of p85, thus it can regulate pathways of 
apoptosis (Park, et al.  2009). 
In human cancer cells, over-expression of miR-206 suppresses expression of 
Notch3 by decreasing levels of both Notch3 mRNA and protein. Notch3 has anti-
apoptotic activity, so when mir -206 targets Notch3 gene, apoptotic cell death is induced 
(Song, et al. 2009). MicroRNA-128 down-regulates Bax and induces apoptosis in 
human embryonic kidney cells. And also over-expression of mir-128 up-regulates Bcl-2 
in SH-SY5Y neuroblastoma cells (Guidi, et al. 2010). miR-125b inhibites apoptosis in 
camptothecin induced human cancer cell lines so, down-regulation of miR-125b  may 
be a novel approach for the treatment of cancer  (Zeng, et al. 2012).  
miR-425 and miR-17* regulate apoptosis in Hela cells are unknown. In this 
study, it is aimed to identify the function of these miRNAs in CPT-induced apoptosis in 
HELA cells. These candidate miRNAs were selected from deep sequencing data that 
includes  screening of 1481 miRNAs after cells were treated with CPT when the 
miRNAs are compared with un-treated control group, it was observed that some 
miRNAs showed strikingly up or down-regulation and these candidates were selected 
among them because of their unknown function in CPT induced apoptosis in HELA 
cells.  
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1. Materials 
 
Cervical cancer (HeLa) cell lines were used in this study were purchased from 
the American Type Culture Collection. Camptothecin was obtained from Sigma. 
Annexin V PE and 7AAD were provided from Becton Dickonson (BD). Metafectene-
Pro transfection kit was purchased from Biontex Laboratories GmbH. miRNA mimics 
(mir-17* and mir-425) were obtained from Ambion. And PE conjugated Rabbit anti-
active caspase-3 antibody was provided from BD Pharmingen. Perm and fix buffer were 
purchased from biolegend.  
 
2.2. Cell Culture 
 
Hela cell lines were used in this study and cultured in RPMI 1640 (Gibco) 
supplemented with L-glutamine, 10% fetal bovine serum (GIBCO), 2% penicillin-
streptomycin (Biochrom AG) in an atmosphere of 5% CO2 at 37oC. Cells were passaged 
every 48 hours.  
Camptothecin dose and treatment time were optimized to capture cells at the 
early apoptotic stage. 3x105 cells were seeded for camptothecin (Sigma–Aldrich) 
treatment and the cells were treated at two time points ( 32, 48 hours) and for five 
different concentration (2µM, 4µM, 8µM, 16µM, 32µM). Camptothecin was dissolved 
in DMSO (Applichem) at a concentration of 10 mg/ml (28700 µM) as stock solution. 
Working concentrations were prepared by serial dilution in culture media composed of 
RPMI 1640 supplemented with 10% FBS. Cell culture was set up in a 500 l volume 
and CPT was added and pipeting one time for homogenization and incubated at 37oC, in 
5% CO2 incubator. 

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2.3. Immunoflorescent Labeling 
 
Apoptosis was measured by flow cytometry after labeling with Annexin V PE 
and 7AAD (BD Pharmingen). Phosphotidylserine layer of the cell membrane was 
flipped inside out in apoptotic cells providing binding site for annexin V. Upon 
apoptosis progression, membrane integrity was lost and 7AAD was bound to DNA as 
DNA was fragmented. Following treatment with camptothecin, culture media was 
removed by centrifugation at 500xg, +4oC  for 5 minutes. The supernatant was aspired 
by vacuum and cells were washed with 1XPBS (Gibco) and centrifuged as before. The 
pellet was re-suspended in 20 L of Annexin-binding buffer (BD Pharmingen) followed 
by incubation with 10 L Annexin V PE and 10 L 7AAD (Annexin diluted 1:5 and 
7AAD 1:10 diluted in 1XPBS containing 0,1% NaN3) for 20 minutes at room 
temperature in a dark place. Then, 160 L of Ca++ binding buffer was added to the 
samples and loaded on 96-well plates for analysis by flow cytometry (BD FacsArray). 
Cells were monitored in dot-blot and histogram graph. In dot blot analysis cells were 
distributed in four parts indicative of various stages of apoptosis. Early apoptotic 
annexin-positive, 7AAD-negative cells were distributed in Q1 part whereas double 
positive (annexin positive 7AAD positive) apoptotic cells in Q2. Q3 part showed 
annexin and 7AAD negative live population. Membrane integrity was completely 
distorted in late apoptotic population which was annexin negative 7AAD positive and 
monitored in Q4 part. Data analysis was performed by MS Excel.  
 
2.4. Transfection  
 
Hela cells were transfected with  100nM miRNA mimics by using Metafectene-
pro transfection kit (Biontex Lab). For transfection 3x105 cells were seeded before the 
day of transfection and on day of transfection cells were transfected with miRNA 
mimics according to instruction of Metafectene-pro and after 24h incubation for over-
expression, cells were harvested. Then some group of cells were used to measure 
apoptosis ratio and the other transfected cells were seeded at 3x105 cells per dish in 500 


µl medium for  CPT treatment and treated with 16µM CPT  for 48h at 37oC in 5% CO2 
incubator. After 48h, cells were harvested and labeled with Annexin V PE and 7AAD 
(BD Pharmingen) to measure apoptosis ratio by flow cytometry.  
 
2.5. Caspase Activitiy Assay 
 
Activities of caspase-3 was measured by using PE conjugated Rabbit anti-active 
caspase-3 antibody (BD Pharmingen) with Flow Cytometry. Firstly Hela cells were 
centrifuged to removed their medium at 500xg, +4oC  for 5 minutes. Then washed with 
1XPBS and 100µl fix buffer (1:10 diluted in 1XPBS) was added and incubated 10 
minutes in the dark. After incubation 300µl 1XPBS was added and centrifuged at 
500xg, +4oC  for 5 minutes. Then 100µl permeabilization buffer (1:10 diluted in 
1XPBS) was added and incubated for 15 minutes after incubation, 300µl 1XPBS was 
added and centrifuged at 500xg, +4oC  for 5 minutes. And 5µl anti-active caspase-3 
antibody was added to each well and incubated for 30 minutes in the dark. After 
incubation cells were washed 2 times with 1XPBS and the pellets were re-suspended in 
200µl 1XPBS and the samples loaded on 96-well plates for analysis by flow cytometry. 
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CHAPTER 3 
 
RESULTS AND DISCUSSION 
 
3.1. Dose Response and Time Point Assay for Camptothecin-induced 
Apoptosis in Hela cell lines 
 
Camptothecin-induced apoptosis in Hela cell line was optimized in order to 
capture cells at the early apoptotic stage for this, Hela cells were treated with CPT at 
concentrations between 2-32 µM for 32 and 48h and the apoptosis ratio were detected 
using flow cytometry. For 32h CPT treatment, up to 20% of annexin positive cells were 
observed (Figure 3.1). 
 
 
 
Figure 3.1.  Camptothecin dose response graph for 32 hours between concentrations 2-32 µM. Hela cells 
were treated with CPT (camptothecin) at concentration between 2-32µM for 32h and after 
32h apoptotic rate was detected by Flow Cytometry. Observed highest annexin positive cells 
was 20%. 
 
In 32h CPT treatment, we observed that 20% annexin positive cells as a highest 
apoptotic percentage at 16 and 32µM CPT concentration. But we aimed to reach at least 
40-50% apoptotic ratio so, 48h treatment was carried out because 24h CPT treatment 
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showed that there is no significant differences in apoptotic ratio between these CPT 
concentration and dose dependency was not observed (Figure 3.1).  
 
 

Figure 3.2.  Camptothecin dose response for 48h. In this time point, cells were treated with camptothecin 
between concentration  2-32µM and the highest concentration of annexin positive cells was 
measured by Flow Cytometry  as 55%  at 32µM camptothecin. 
 
  
In 48h CPT treatment, 45-55% annexin positive cells were observed at 16µM in 
48h thus this concentration and time point were selected as a camptothecin dose  to 
induce apoptosis in Hela cells. 
 Dot blot analysis showed that in 48h camptothecin treatment more cells passed 
to annexin positive region (Q1) from region that shows live cells percentage (Q3) as 
compared with Q1 region in 32h camptothecin treatment. Thus Q1 region in 48h 
camptothecin treatment had more cells than in Q1 region of  32h  treatment. At 16µM 
camptothecin in 48h, Q1 region has 45% annexin positive cells whereas 20% annexin 
positive cells were detected in Q1 region in 24h camptothecin treatment. So, the data 
indicated that camptothecin induces apoptosis in a time dependent manner. 
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(a) 32h                                                                (b) 48h 
 
 
Figure 3.3. Dot blot analysis of dose response assay. a) 32h treatment with 16µM camptothecin. b) 48h 
treatment with 16µM camptothecin. As explained in Materials and Methods part Hela cells 
were labeled with Annexin PE and 7AAD. Annexin-positive cells distributed in Q1 part 
represents early apoptotic phase whereas annexin and 7AAD-positive cells in Q2 part are at 
apoptotic phase. 7AAD-positive cells in Q4 are at the late apoptotic phase. Q3 part shows live 
cells.  Whereas in 32h treatment, Q1 region had 20% annexin positive cells after 48h 
camptothecin treatment  45% annexin positive cells were observed  in Q1 region also there 
was a time dependent increase in cell number of Q2 and Q4 region  same as Q1. 
 
 
3.2. miR-17* and miR-425 Response to Camptothecin Induced      
Apoptosis in Hela cells 
 
To investigate the function of miR-17* and miR-425 in CPT induced apoptosis, 
Hela cells were transfected with miR-17* and miR-425  mimics individually for 24h 
and after transfection for 24h, some cells were used to measure apoptosis and remainder 
cells were treated with CPT for 48h.   
 After 24h transfection, figure 3.5 shows that miR-17* and miR-425 increase 
apoptosis in 7AAD positive cells approximately 2 fold as compared with Transfection 
Reagent controls (TR).  In TR control group 7,5% 7AAD positive cells were observed 
whereas in miR-17* overexpressed cells had 14% and miR-425 overexpressed cells had 
16%. This result showed that in miR-17* and miR-425 overexpressed cells, apoptotic 
rate increased from 7,5% to 14-16% (Figure 3.5). 
 
 


 
 
Figure 3.4. After 24h transfection of Hela cells with miR-17* and miR-425. In the figure, Negative 
(NEG) represents cells which is not transfeted and treated with transfection reagent , 
Transfection Reagent control group(TR) represents cells containing  Transfection Reagent in 
their medium  and miR-17* and miR-425 represent cells were  transfected with miR-17* or  
miR-425.  
 
To show function of these miRNAs in CPT-induced apoptosis in Hela cells, the 
miR-17* and miR-425 overexpressed cells were treated with 16µM camptothecin for 
48h and after 48h cells were labeled with Annexin V PE and 7AAD to measure 
apoptosis by Flow Cytometry (Figure 3.6). 
 
 
 
Figure 3.5. miR-17* and miR-425 function in CPT-induced apoptosis. miR-17* and miR-425 
overexpressed cells were treated with 16µM camptothecin for 48h. NEG-CPT represents 
only CPT treated cells, TR- CPT represents both transfection reagent and CPT treated cells, 
miR-17* and miR-425 CPT represents miR-17* or mir-425 overexpressed and CPT treated 
cells. 
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After 48h of CPT treatment the results showed that in miRNA overexpressed 
cells, double positive (Annexin and 7AAD)  cells number in Q2 region and 7AAD 
positive cell number in Q4 region higher than TR control group (Transfection Reagent 
treated control group). For CPT treated cells as a control group TR CPT and NEG CPT 
were used and for non - treated group with CPT, TR and NEG were used as a control 
group. When miR-17* overexpressed cells are compared with TR group, miR-17* 
overexpressed cells have 11,5% double positive cells in Q2 region and 7,4% 7AAD 
positive cells in Q4 region meanwhile TR group has 5% double and 7% 7AAD positive 
cells the data showed that  there was  2 fold differences in double positive cells and 3,5 
fold differences in 7AAD positive cells between miR-17* or miR-425 overexpressed 
cells and  TR control groups. (Figure 3.6) 
 Cells which were miR-17* or miR-425 overexpressed and treated with CPT had 
respectively, 34%  and 30% 7AAD positive cells in Q4 region as compared with TR 
CPT( treated with both transfection reagent and CPT) control group which had  21% 
7AAD positive cells.   
 
3.3. Active Caspase-3 Level in Camptothecin Induced Apoptosis in 
Hela Cells 
 
Caspases are the executioners of apoptosis and the another evidence that shows 
induced caspase-dependent apoptosis. Caspases are synthesized as inactive pro-
enzymes then activated and Caspase-3 is one of the key executioners of apoptosis. 
(Gerald M.C 1997). 
 Hela cells were treated with camptothecin for 24h and 48h to show increasing 
active caspase-3 level with apoptosis which results in camptothecin treatment.. Then 
cells were treated with anti-active caspase-3 antibody and the result was detected by 
using Flow Cytometry. Figure 3.7 shows the results. 
In 24h camptothecin treatment, 7% active caspase-3 positive cells were observed 
whereas camptothecin un-treated control group had 2,7% active caspase positive cells. 
 
                       
                         



        
(a)  24h camptothecin treatment                        (b) 48h camptothecin treatment 
 
Figure 3.6.  Measurerment of  active caspase-3 level after 24h and 48h camptothecin treatment. (a) after 
24h CPT treatment, 7%  active caspase-3 positive cells were observed as compared with un-
treated control group. (b) after 48h CPT treatment approximately %55 active caspase-3 
positive cells were observed whereas un-treated group had %16. 
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3.4. Active Caspase-3 Level in miR-17* and miR-425 Over-expressed 
Hela Cells after 48h Camptothecin Treatment 
 
As it was explained before, Hela cells first were transfected with candidate 
miRNAs individually for over-expression then treated with camptothecin for 48h and 
some group of transfected Hela cells were not treated with camptothecin to used as a 
control.  
 
          
 
 Figure 3.7. Active caspase-3 level in miR-17* or miR-425 transfected Hela cells. TR shows trasfection 
reagent control group, miR-17* shows miR-17* transfected cells and miR-425 shows      
miR-425 transfected cells. 
 
 
In miRNA overexpressed Hela cells, active caspase-3 level was higher than un-
transfected control but significant difference was not observed (Figure 3.8). 
 
        
       
            Figure 3.8. Active caspase-3 level in miR-17* or miR-425 over-expressed and 48h    
                              camptothecin treated cells.                          
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After 48h camptothecin treatment in miR-17* or miR-425 over-expressed cells it 
was observed that miRNA over-expressed cells have higher active caspase-3 activity 
than un-transfected control (TR CPT). In this data a significant difference also was 
observed (P value =0,02) when miRNA transfected groups and control were compared 
 (Figure 3.9). 
So, the data showed that active caspase-3 level increases by camptothecin in a 
time dependent manner. 
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CHAPTER 4 
 
 CONCLUSION 
 
 
In this study, we identified functions of miR-17* and miR-425 in CPT-induced 
apoptosis in Hela cells for the first time. To show functions of these miRNAs in CPT-
induced apoptosis, firstly CPT dose was found to induce apoptosis in Hela cells and the 
results reported that CPT induces apoptosis in a time dependent manner. After that  
Hela cells were transfected with miR-17* and miR-425 individually and after 24h 
transfection for overexpression, cells were treated with camptothecin and the results 
demonstrated that apoptosis rate increased at late stage of apoptosis in miR-17* and 
miR-425 overexpressed cells as compared with negative controls. So, miR-17* and 
miR-425 showed pro-apoptotic function in CPT-induced Hela cells. 
This data also was supported with measurment of active caspase-3 level. 
Caspases are the executioners of  apoptosis and the increasing caspase level  shows 
apoptosis. Thus, caspase-3 that is one of the key executioners of apoptosis level was 
measured  and the results showed that active caspase-3 level is higher in miR-17* or 
miR-425 overexpressed and CPT treated cells as compared with their negative controls. 
So, the data demonstrated that miR-17* and miR-425 function as pro-apoptotic 
regulators in CPT-induced apoptosis in Hela cells.    
miRNAs have a role in regulation of apoptosis by targeting genes involved in 
apoptotic pathways and these genes can be potential targets of one or more of these 
miRNAs (Subramanian, et al. 2010). For future aspects, targets of miR-17* and miR-
425 will be identified by TargetScan which is target screening  programme and targets 
related with apoptosis will be chosen and will be verified by qPCR. So we will learn 
which genes targeted by these miRNAs in regulation of apoptosis in Hela cells and with 
this study, we contributed to litreture about fuction of miR-17* and miR-425 in 
apoptosis and also this data may help in the development of potential therapeutics 
against cancer.  
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